scispace - formally typeset
Open AccessJournal ArticleDOI

The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic

xing feng, +1 more
- 01 Feb 2022 - 
- Vol. 185, Iss: 3, pp 447-456.e11
TLDR
In this paper , the authors reported that the Omicron spike was resistant against most therapeutic antibodies but remained susceptible to inhibition by sotrovimab, and that double immunization with BNT162b2 might not adequately protect against severe disease induced by this variant.
About
This article is published in Cell.The article was published on 2022-02-01 and is currently open access. It has received 603 citations till now. The article focuses on the topics: Neutralization & Antibody.

read more

Citations
More filters
Journal ArticleDOI

Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines

TL;DR: This review focused on the genomics, transmission, and effectiveness of vaccines against the Omicron variant, which will be helpful for further investigation of a new variant of SARS‐CoV‐2.
Journal ArticleDOI

Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron

TL;DR: In this paper , the authors showed that the Omicron (B.1.529) variant of SARS-CoV-2 is substantially attenuated in human Calu3 and Caco2 cells.
Journal ArticleDOI

Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement

TL;DR: In this paper , the authors determined the crystal structures of the spike protein and the receptor-binding domain bound to the broadly neutralizing sarbecovirus monoclonal antibody (mAb) S309 (the parent mAb of sotrovimab) and to the human ACE2 receptor.
Journal ArticleDOI

SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

Brian J. Willett, +672 more
- 07 Jul 2022 - 
TL;DR: In this article , the authors demonstrate substantial evasion of neutralization by Omicron BA.1 and BA.2 variants in vitro using sera from individuals vaccinated with ChAdOx1, BNT162b2 and mRNA-1273.529.
References
More filters
Journal ArticleDOI

A pneumonia outbreak associated with a new coronavirus of probable bat origin

TL;DR: Identification and characterization of a new coronavirus (2019-nCoV), which caused an epidemic of acute respiratory syndrome in humans in Wuhan, China, and it is shown that this virus belongs to the species of SARSr-CoV, indicates that the virus is related to a bat coronav virus.
Journal ArticleDOI

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

Merryn Voysey, +81 more
- 09 Jan 2021 - 
TL;DR: ChAdOx1 nCoV-19 has an acceptable safety profile and has been found to be efficacious against symptomatic COVID-19 in this interim analysis of ongoing clinical trials.
Related Papers (5)